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Abstract
Background: Cytoplasmic filamentous rods and rings (RR) structures were identified using human autoantibodies as probes.
In the present study, the formation of these conserved structures in mammalian cells and functions linked to these
structures were examined.
Methodology/Principal Findings: Distinct cytoplasmic rods (,3–10 mm in length) and rings (,2–5 mm in diameter) in HEp-
2 cells were initially observed in immunofluorescence using human autoantibodies. Co-localization studies revealed that,
although RR had filament-like features, they were not enriched in actin, tubulin, or vimentin, and not associated with
centrosomes or other known cytoplasmic structures. Further independent studies revealed that two key enzymes in the
nucleotide synthetic pathway cytidine triphosphate synthase 1 (CTPS1) and inosine monophosphate dehydrogenase 2
(IMPDH2) were highly enriched in RR. CTPS1 enzyme inhibitors 6-diazo-5-oxo-L-norleucine and Acivicin as well as the
IMPDH2 inhibitor Ribavirin exhibited dose-dependent induction of RR in .95% of cells in all cancer cell lines tested as well
as mouse primary cells. RR formation by lower concentration of Ribavirin was enhanced in IMPDH2-knockdown HeLa cells
whereas it was inhibited in GFP-IMPDH2 overexpressed HeLa cells. Interestingly, RR were detected readily in untreated
mouse embryonic stem cells (.95%); upon retinoic acid differentiation, RR disassembled in these cells but reformed when
treated with Acivicin.
Conclusions/Significance: RR formation represented response to disturbances in the CTP or GTP synthetic pathways in
cancer cell lines and mouse primary cells and RR are the convergence physical structures in these pathways. The availability
of specific markers for these conserved structures and the ability to induce formation in vitro will allow further investigations
in structure and function of RR in many biological systems in health and diseases.
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Introduction
Over the past few decades many human autoantibodies have
emerged as significant disease-specific markers for systemic
rheumatic diseases [1]. These autoantibodies are mainly directed
against intracellular macromolecular complexes or particles, such
as nucleosomes and small nuclear/cytoplasmic ribonucleoproteins
[1]. Thus, human autoantibodies have also served as useful probes
for exploring subcellular structures and functions because of their
unexpected specificity to novel self-antigens. Examples of signif-
icant uses of human autoantibodies in further characterization of
novel subcellular structures included the identification of p80-
coilin in Cajal bodies (formerly known as coiled bodies) [2] and
GW182 in GW bodies [3]. Within the past few years, our
laboratories identified novel human autoantibodies that recog-
nized unique cytoplasmic structures described provisionally as rods
and rings. The current study reports the identification of CTPS1
and IMPDH2 as components associated with these mammalian
RR.
CTPS1 and IMPDH2 are key enzymes in the biosynthetic
pathway for cytidine triphosphate (CTP) and guanosine triphos-
phate (GTP), respectively. CTPS1 catalyzes the rate-limiting step
in generating CTP from uridine triphosphate. CTP is involved in
nucleic acid and phospholipid biosynthesis and plays an important
role in controlling cellular proliferation [4]. Two isoforms, CTPS1
and CTPS2, have been identified with 74% amino acid similarity.
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29The 67 kDa CTPS1 is a target for antiviral, antineoplastic, and
antiparasitic drug development. Currently available specific
inhibitors of CTPS1 include Acivicin and 6-diazo-5-oxo-L-
norleucine (DON) [5].
The oxidation of inosine monophosphate to xanthosine
monophosphate is the rate-limiting step in the de novo guanine
synthetic pathway catalyzed by IMPDH2, which is known to have
a role in regulating cell proliferation. Due to its rate-limiting
property, it has been a major target for immunosuppressive,
antiviral, and cancer chemotherapy. Two isoforms of IMPDH,
IMPDH1 and IMPDH2, sharing 84.0% sequence identity and
95.3% similarity have been identified and both are 56–58 kDa
proteins that function as tetramers [6]. A study on the regulation of
IMPDH with mycophenolic acid (MPA) showed that MPA binds
to IMPDH and causes a conformational change resulting in the
formation of inactive angular aggregates [7]. IMPDH2 inhibitors
such as MPA, Ribavirin, and Tiazofurin are currently used for
various medical conditions [8–11].
In the current report, inhibiting either CTPS1 or IMPDH2
using different compounds demonstrated induction of RR in a
variety of cell types. More importantly, RR were identified in
mouse embryonic stem cells (ESCs) and their disassembly was
observed upon induced differentiation.
Results
Rods and rings in the cytoplasm
A distinct cytoplasmic pattern was first identified in a routine
antinuclear antibody (ANA) test using HEp-2 cell slides from
INOVA Diagnostics Inc. These ANA slides are generally used in
clinical laboratories for patients developing antibodies to self-
proteins/antigens as a diagnostic screening assay for autoimmune
diseases. The structures recognized by a prototype human serum
604 were distinct cytoplasmic rods (,3–10 mm in length) and rings
(,2–5 mm in diameter, Figure 1). On average, there are one to
two rods and/or rings per cell including some interesting apparent
intermediate structures such as a figure ‘‘8’’, an elongated ring,
twisted ring, rods with pin loops at one end, as well as some that
appeared to be transitioning from rods to this peculiar form
(Figure 2). Immunofluorescence was performed to visualize the
RR structure and location with respect to the nucleus and the
Golgi complex (Figure 1A). Some rods often align adjacent to the
nucleus (short arrows, ,40% frequency) or perpendicular to the
nucleus (long arrows, ,40% frequency), and rings may be found
in the cytoplasm (arrowheads, 5–10% frequency). RR are
expressed in some mitotic cells; however, co-staining studies with
anti-centromere protein F (CENP-F), showed that the expression
of either rods or rings were independent of the cell cycle, as they
appear in all stages (Figure 3). CENP-F is a cell cycle marker that
has little or no expression at the G1 phase, with increasing level
during the S phase, and reaching highest expression during late S
and G2 phases [12,13].
To examine the relationship of RR with other known
cytoplasmic organelles, co-localization studies were performed
using known markers for cytoplasmic structures. Co-staining
studies with antibodies to the Golgi complex showed that RR were
independent of the Golgi complex (Figure 1A). Although many
rods appeared to be in the same vicinity as the Golgi complex,
there are also many clear-cut examples of rods unassociated with
this subcellular structure. Cytoplasmic structures, referred to as
‘‘actin rockets,’’ were previously described in bacteria-infected cells
[14]. To determine whether RR are related to actin rockets, co-
staining with mouse anti-actin antibody was performed to show
that RR are not enriched in actin (data not shown). Furthermore,
upon careful examination at higher magnification, the HEp-2 cells
in our laboratory were not contaminated with bacteria and cell
viability was .99%. Since RR are filamentous, co-staining
experiments were also performed to determine whether tubulin
or vimentin, was enriched in RR. Costaining showed that RR are
not enriched in tubulin (Figure 1B–D). Co-staining of human
prototype serum 604 and anti-vimentin antibody ruled out
enrichment of RR with vimentin (Figure 1E–G).
Another initial consideration was that primary cilia, which
function as nonmotile sensory organelles and have a rod-like
appearance [15], could be a possible candidate. To rule out RR as
primary cilia, a co-staining study with anti-pericentrin, which
Figure 1. The distribution of cytoplasmic rods and rings was independent of the Golgi complex and centrosomes, and these
structures were not enriched in tubulin or vimentin. (A) Merged image of HEp-2 co-stained with human anti-RR prototype serum 604/Alexa
488 goat anti-human Ig (green) and rabbit anti-giantin (Golgi marker)/Alexa 568 goat anti-rabbit Ig (red). Rods are often presented adjacent (short
arrows) or perpendicular (long arrows) to the nucleus while rings (arrowheads) are found either 1 or 2 to a cell. M, mitotic cell. HEp-2 cells were also
co-stained with serum 604/Alexa 488 goat anti-human Ig (green, B,E,H) and different cytoplasmic markers using mouse anti-tubulin (C), anti-vimentin
(F), anti-pericentrin (I), followed by Alexa 568 goat anti-mouse Ig (red). Nuclei were counterstained with DAPI (blue). Bar, 10 mm.
doi:10.1371/journal.pone.0029690.g001
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precursors of primary cilia and are often located at the ends of the
primary cilia. Since centrosomes were not located at the ends of
rods recognized by human prototype serum 604 (Figure 1H–J),
these rods are not primary cilia. In fact, there is no noticeable
association of either rods or rings with centrosomes. Furthermore,
upon closer examination, the fact that ring-type structures have
never been observed for primary cilia is consistent with the
conclusion.
These findings are highly reproducible using HEp-2 cell
substrate from INOVA, as well as home-made cell slides prepared
with inhibitor-treated cells (see below) using various commonly
used fixatives in biological laboratories including acetone at
220uC for 5 minutes, acetone/methanol (1:1) for 10 minutes, or
3% paraformaldehyde and 0.1% triton-X. Co-staining experi-
ments with known subcellular markers showed no association with
known cytoplasmic organelles such as GW bodies (data not
shown).
Identification of CTPS1 and IMPDH2 as RR components
During the initial phase of our study, CTPS1 became a
candidate RR protein because, in the Carnegie protein trap study,
it was noted that similar rod-like structures were observed in
Drosophila embryos carrying GFP-CTPS1 [16,17]. Co-staining
studies with rabbit anti-Drosophila CTPS antiserum showed
localization of CTPS1 to RR, identified with prototype human
anti-RR serum It2006 (Figure 4A). As there are 75.0% sequence
identity and 89.8% similarity between human CTPS1 and
CTPS2, antiserum to CTPS1 probably crossreacts with CTPS2
and both might be components of RR.
A second candidate RR protein was postulated in part because
of an isolated ring-like structure in the cytoplasm identified by a
Figure 2. Examples of various intermediate RR structures in HEp-2 cells stained with human serum 604 (green) and counterstained
with DAPI (blue). (A) Figure ‘‘8’’ structure (arrowhead) with a curved rod adjacent to the nuclear envelope; (B) elongated ring; (C) elongated, twisted
ring (short arrow); (D) rod with a pin-loop (long arrow); (E) Figure ‘‘8’’ structure (arrowhead); (F) another rod with pin-loop (long arrow). Nuclei were
counterstained with DAPI (blue). Bar, 5 mm.
doi:10.1371/journal.pone.0029690.g002
Figure 3. The expression of rods versus rings was not correlated with the cell cycle. HEp-2 cells were co-stained with rabbit anti-CENP-F/
Alexa 568 goat anti-rabbit IgG (A) and human anti-RR serum 604/Alexa 488 goat anti-human IgG (B). G1 cells had little or no CENP-F staining, whereas
late S/G2 and mitotic (M) cells showed strong staining for CENP-F. Nuclei counterstained with DAPI (blue). Bar, 10 mm.
doi:10.1371/journal.pone.0029690.g003
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and the consideration that CTPS1 and IMPDH2 are enzymes in
closely linked pathways as discussed below. In the first experiment
to demonstrate whether IMPDH2 was localized to RR, a
commercially available rabbit anti-IMPDH2 antibody was used
to co-stain HEp-2 cells. Anti-IMPDH2 stained both rods and rings
(Figure 4B, arrows). Immunoprecipitation analysis using an extract
of [
35S]-methionine-labeled K562 cells showed that rabbit anti-
IMPDH2 and It2006 both pulled down a 55 kDa protein
(Figure 4C). Furthermore, IP-Western analysis confirmed that
the 55 kDa protein immunoprecipitated by It2006 was IMPDH2,
since it was recognized by both mouse monoclonal anti-IMPDH2
and rabbit anti-IMPDH2 (Figure 4D). Since human IMPDH1 and
IMPDH2 have 95.3% sequence similarity, our data cannot
exclude IMPDH1 is also enriched in RR.
Expression of rods and rings in cultured cells
HEp-2 cell slides from INOVA Diagnostics have been
consistently positive for RR, tested from lot to lot, since this study
was initiated over five years ago. The same was not true for HEp-2
cell ANA slides from other manufacturers examined to date, with
staining varying from completely negative to granular or diffused
cytoplasmic staining. This could be the explanation for why the
subcellular staining observed by Blu ¨thner et al [18] was largely
different from ours, except for showing one or two isolated ring
structures. These differences among products from several
manufacturers remains a question not completely resolved, but
may stem from differences in culture conditions, proprietary
sample processing, or both. Homegrown HEp-2 cells on coverslips
or 8-chambered slides have generally not been positive for RR
staining unless cells were kept in rapidly dividing log phase or
under subconfluent cell density. Confluent cultures were generally
negative for RR. Variability from experiment to experiment was
clearly observed, and on average only 5–30% of cells were positive
for RR detectable by serum 604 or It2006. Cells were always co-
stained with both human anti-RR and rabbit anti-giantin (Golgi
marker) antibodies to ensure that variables were not introduced in
the fixation and immunostaining steps in these experiments.
Exactly how INOVA Diagnostics can produce highly consistent
HEp-2 cell slides with .95% cells positive for RR staining remains
unresolved, but clearly the difference must stem from their unique
manufacturing methods. Thus, HEp-2 cells do not express RR
under our standard culture conditions. Cells that do not ordinarily
express RR have a diffused cytoplasmic pattern when stained with
prototype human serum (Figure 5A). However, it was noted that
cells recently thawed from liquid nitrogen express RR in about
15% of the cells. Treating cultured cells with 0.015% to 0.5% of
DMSO overnight to simulate freezing medium condition (often
with 10% DMSO) did not induce formation of RR.
Induction of rods and rings in cultured HEp-2 cells
When CTPS1 and IMPDH2 were identified as RR compo-
nents, the next series of experiments focused on the effects of
inhibiting these enzymes. Effects of each drug treatment were
analyzed by immunofluorescence (Figure 5). The first applied was
the CTPS1 inhibitor, DON, on HEp-2 cells cultured at 2 mM, a
functional concentration reported in literature [5,19]. A surprising
finding was that both rods and rings were readily detected in
96.7% of cells after overnight incubation (Figure 5B) compared to
0% in untreated control cells cultured in parallel (Figure 5A). The
RR detected in DON-treated cells were identical in frequency to
those observed in the INOVA HEp-2 slides. A second indepen-
dent CTPS1 inhibitor Acivicin [4,5], as well as the IMPDH2
inhibitor Ribavirin, also showed the ability to induce RR
formation under similar conditions (Figure 5C and D). In addition,
RR induced by 2 mM DON, known to inhibit CTPS1 but not
IMPDH2, were detectable with the anti-IMPDH2 antibody along
with the human anti-RR serum. Therefore, CTPS1 and IMPDH2
appeared to aggregate after induction with either inhibitor to form
RR.
Inhibition of CTPS1 or IMPDH2 induced RR formation in a
concentration-dependent manner (Table 1). The three inhibitors
had different efficiency in the induction of RR formation in HEp-2
cells. Ribavirin was the most potent inducer of RR; even at
concentrations lower than 7.81 mM, Ribavirin induced RR in
nearly all cells, whereas DON and Acivicin did not induce RR
efficiently at these low concentrations (Table 1, p,0.0001).
Figure 4. CTPS1 and IMPDH2 were highly enriched in RR and
human anti-RR prototype serum It2006 recognized IMPDH2.
(A) Enrichment of CTPS1, detected by rabbit anti-CTPS1 (green), to RR
(arrows) identified by It2006 (red). Nuclei were counterstained with
DAPI (blue). (B) IMPDH2 stained by rabbit anti-IMPDH2 (red) localized to
RR (arrows) detected by It2006 (green). Bar, 10 mm. (C) Immunoprecip-
itation (IP) analysis using an extract of [
35S]-methionine-labeled K562
cells and rabbit anti-IMPDH2, It2006, and a second human anti-RR
serum 609. It2006 recognized a 55 kDa protein band that co-migrated
with IMPDH2 immunoprecipitated by rabbit anti-IMPDH2. Serum 609
did not immunoprecipitate the 55 kDa protein. (D) IP-Western blot
demonstrated that serum It2006 immunoprecipitated IMPDH2, which
was recognized by both mouse monoclonal and rabbit anti-IMPDH2
antibodies. NHS, control normal human serum.
doi:10.1371/journal.pone.0029690.g004
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a concentration lower than 0.5 mM (p,0.0001) and vs Acivicin at
a concentration lower than 15.6 mM( p ,0.0001). Induction of RR
by Acivicin vs DON was significant between 0.25 mM and
15.6 mM( p ,0.0001).
There are also differential time requirements for RR induction
in HEp-2 cells treated with inhibitors at a fixed 2 mM
concentration (Table 2). Ribavirin induced RR as early as
30 min and between 1 and 24 h, nearly all cells had RR.
Induction of RR by Ribavirin was significantly faster than DON,
which in turn was significantly faster than Acivicin (Table 2).
On average, cells treated with DON or Acivicin had two RR
per cell (Figure 5B, 5C), while cells treated with Ribavirin had
more than two RR per cell (Figure 5D). The additive effect of two
inhibitors on RR formation was also investigated. Addition of both
DON and Ribavirin at 2 mM did not have a noticeable effect on
RR formation since both alone induced formation of RR in
.95% of treated cells. However, when inhibitors were applied at
lower concentrations and for shorter periods, obvious additive
effects were observed. For example, treatment of HEp-2 cells with
1 mM DON for 3 h induced RR in 52% of cells; however, when
this was combined with 1 mM Ribavirin for 30 min, which alone
induced RR in 13% of cells, RR was detected in 91% of cells. In
addition, when HEp-2 cells were exposed to lower concentrations
of Ribavirin (2 mM, 3 h), the RR structures were small and
difficult to visualize; however when combined with DON (1 mM,
3 h), typical RR structures were observed. Thus, inhibition of both
CTPS1 and IMDPH2 had apparent additive effects on RR
formation, supporting the finding that they aggregated in the same
structures. An unrelated compound, enoxacin, used as an oral
broad-spectrum fluoroquinolone antibacterial agent observed to
enhance miRNA activity [20] served as an additional negative
control as it did not induce RR after 24 h treatment in various
concentrations (10–100 nM). Thus, the inhibition of either CTPS1
or IMPDH2 appeared to be specific for the induction of RR in
HEp-2 cells.
Induction of RR in other cancer and primary cells
To address whether the induction of RR is conserved, multiple
cell lines were analyzed, including other adherent monolayer cell
lines like HeLa (Figure 6A), CAL 27 (Figure 6B), and HCT116
(Figure 6D), as well as a suspension monocytic cell line THP-1
(Figure 6C). Cells were incubated with DON for 24 h and co-
stained with serum It2006 and anti-giantin. All cell lines expressed
RR at a high frequency (,98% for HeLa, CAL 27, and THP-1),
comparable to the frequency observed in HEp-2 cells except
HCT116 cells, with only 35.8% of cells positive for RR. Untreated
cells normally did not show expression of RR, but isolated HeLa
cells showed some cytoplasmic granular staining and THP-1
produced some short ‘‘immature’’ rods. To determine whether the
expression of RR could be observed in species other than human,
mouse 3T3 fibroblasts and rat NRK cells were stained with
It2006. Freshly defrosted 3T3 and NRK often showed expression
of RR (5 to 25% of cells) in the first one or two passages, but their
expression disappeared completely in subsequent passages. The
ability of freshly thawed cells to express RR was not examined
further due to the lack of consistency between batches of frozen
cells. Mouse primary cardiomyocytes, as well as the often co-
purified endothelial cells and fibroblasts isolated from neonatal
heart, did not express RR until induced with 2 mM DON in
overnight culture (Figure 7). Overall 88.4% of cells had detectable
RR, but cardiomyocytes detected by co-staining of actinin had up
to 92.6% showing induced RR (Figure 7B). Thus, RR expression
appeared to be conserved as they could be induced in multiple
immortalized cells, as well as in primary cultured cells.
Induction of RR is quantitatively sensitive to the level of
cellular IMPDH2 protein
To monitor the formation of RR, the use of GFP fusion
constructs was explored. HeLa cells were transfected with GFP-
IMPDH2 (Figure 8A–C) or the GFP vector alone (Figure 8D–F).
Following transfection, cells were treated with 2 mM of Ribavirin
for 24 h, and then fixed and stained with rabbit anti-IMPDH2.
GFP-IMPDH2 transfected cells had brighter fluorescence com-
pared to untransfected cells, confirming the expression of
recombinant IMPDH2 (Figure 8A). Surprisingly, GFP-IMPDH2
transfected cells did not show RR after Ribavirin induction,
whereas neighboring untransfected cells showed RR as expected
(Figure 8C). To rule out transfection-induced artifacts interfering
with the induction of RR, the induction of RR in control GFP-
vector transfected cells was not affected by the transfection
(Figure 8F). Series of experiments were performed to explore
whether the lowest expression of transfected GFP-IMPDH2 could
produce cells with GFP-labeled RR by titrating the amount of
transfected plasmid and by reducing the time of transfection. None
Figure 5. Inhibition of CTPS1- or IMPDH2-induced formation of
rods and rings. Untreated HEp-2 cells (A) and cells treated with
inhibitors 2 mM DON (CTPS inhibitor, B), 2 mM Acivicin (CTPS inhibitor,
C), or 2 mM Ribavirin (IMPDH2 inhibitor, D) for 24 h were co-stained
with human anti-RR serum It2006 (green) and rabbit anti-giantin (red).
Nuclei were counterstained with DAPI (blue). The percentage of cells
with RR displayed for each experiment is shown in the lower right
corner with the total number of cells counted indicated in parentheses.
Bar, 10 mm.
doi:10.1371/journal.pone.0029690.g005
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Therefore, the overexpression of IMPDH2 appeared to inhibit
formation of RR, even at high concentrations of Ribavirin. When
these GFP-IMPDH2 transfected cells were exposed to higher
concentrations of Ribavirin up to 8 mM, only small aggregates
were observed in some of the transfected cells.
Since overexpression of IMPDH2 inhibited RR induction, the
next series of experiments were to address whether knockdown of
CTPS1 or IMPDH2 would affect the induction of RR. The
adopted strategy was to examine cells transfected with either
CTPS1 siRNA (siCTPS1) or IMPDH2 siRNA (siIMPDH2). Thus,
HeLa cells were either untransfected or transfected with siCTPS1
or siIMPDH2 for 44 h, followed by an additional 4 h of
incubation with three different concentrations of Ribavirin at
2 mM, 0.2 mM, or 0.05 mM. The 2 mM Ribavirin concentration
was selected as the highest concentration tested and 0.2 mM was
selected as the lowest based on the data presented in Table 1. Not
shown in Table 1 for HEp-2 cells, 0.05 mM Ribavirin was tested in
HeLa cells and was shown to be ineffective in the induction of RR.
The induction of RR was monitored by double immunofluores-
cence using rabbit anti-IMPDH2 antibody as well as It2006. After
siIMPDH2 knockdown, Western blot analysis showed reduction of
Table 1. Concentration-dependent induction of RR in HEp-2 cells using different CTPS1 and IMPDH2 inhibitors for 24 h.
Percent HEp-2 cells with RR (total counted); number of experiments
Drug Concentration Ribavirin
1 DON
2 Acivicin
3
2m M
4 98.2% (231); n=3 94.8% (98); n=5 97.3% (226); n=4
1m M
4 98.9% (194); n=3 87.9% (108); n=3 98.5% (69); n=1
0.5 mM
4 99.2% (142); n=2 87.2% (102); n=2 94.3% (172); n=3
0.25 mM
5 98.5% (135); n=2 28.4% (116); n=2 94.5% (109); n=3
125 mM
5 94.4% (108); n=2 29.1% (79); n=2 98.3% (121); n=3
62.5 mM
5 90.8% (120); n=2 22.9% (96); n=2 98.1% (53); n=2
31.3 mM
5 98.9% (183); n=2 23.3% (124); n=2 95.2% (62); n=2
15.6 mM
6 96.8% (160); n=2 11.6% (155); n=2 30.4% (23); n=2
7.8 mM
7 94.1% (202); n=2 5.1% (118); n=2 0% (45); n=2
0.2 mM
7 95.6% (249); n=3 2.8% (105); n=2 0% (82); n=1
0 mM
4 0% (300); n=3 0% (300); n=3 0% (300); n=3
1Ribavirin induced RR in nearly all cells regardless of the tested concentration (0.2 mM–2 mM). There is no statistical significance (ns) between concentrations after
Bonferroni’s adjustment except with untreated control (0 mM; p.0.005);
2DON induced RR in most cells at concentrations higher than 0.5 mM (p,0.005, 0.5 mM or higher vs any lower concentration);
3Acivicin started to induce RR at 15.6 mM and concentrations higher than 31.3 mM, nearly all cells had RR (p,0.005 vs lower concentration) and no difference between
concentrations was observed;
4ns between Ribavirin, DON, or Acivicin;
5Ribavirin vs DON, p,0.0001, Ribavirin vs Acivicin, ns, DON vs Acivicin, p,0.0001;
6Ribavirin vs DON, p,0.0001, Ribavirin vs Acivicin, p,0.0001, DON vs Acivicin, p=0.024;
7Ribavirin vs DON, p,0.0001, Ribavirin vs Acivicin, p,0.0001, DON vs Acivicin, ns.
doi:10.1371/journal.pone.0029690.t001
Table 2. Differential time requirements for RR induction in HEp-2 cells treated with different CTPS1 and IMPDH2 inhibitors at
2 mM concentration.
Percent HEp-2 cells with RR (total counted); number of experiments
Time after addition Ribavirin
1 DON
2 Acivicin
3
0 min 0% (300); n=3 0% (300); n=3 0% (300); n=3
30 min
4 15.2% (67); n=2 8.3% (120); n=1 5.2% (102); n=1
1h
5 98.1% (53); n=2 13.7% (80); n=3 11.5% (87); n=3
2h
5 95.2% (42); n=2 20.2% (89); n=2 19.3% (119); n=2
3h
6 98.1% (55); n=2 70.5% (88); n=3 39.4% (109); n=2
24 h
7 98.2% (231); n=3 94.8% (98); n=5 97.3% (226); n=4
1Ribavirin induced RR as early as 30 min and between 1 to 24 h, nearly all cells had RR (p,0.0001, 0 min vs all time points and 30 min vs 1 to 24 h). There is no statistical
significance between 1 to 24 h after Bonferroni’s adjustment;
2Induction of RR by DON was slower than Ribavirin (p,0.0001, 1, 2, and 3 h; ns, 30 min and 24 h) and the percentage of RR positive cells gradually increased after 1–3 h
and was nearly all cells at 24 h.
3Acivicin had similar pattern to DON in which RR positive cells gradually increased after 1 h and nearly all cells at 24 h.
4Ribavirin vs DON and DON vs Acivicin, ns; Ribavirin vs Acivicin, p=0.03;
5Ribavirin vs DON and Ribavirin vs Acivicin, p,0.0001; DON vs Acivicin, ns;
6Ribavirin vs DON, DON vs Acivicin, Ribavirin vs Acivicin, p,0.0001;
7ns between Ribavirin, DON, and Acivicin.
doi:10.1371/journal.pone.0029690.t002
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no effect on the level of IMPDH2 as expected, although siCTPS1
was confirmed by real-time PCR to be functional with 62%
CTPS1 mRNA knockdown (Figure 9A). The number of cells with
RR were counted and plotted as a percentage (Figure 9B). While
siCTPS1 transfection did not affect the percentage of cells positive
for RR in all three concentrations of Ribavirin examined,
knockdown of IMPDH2 showed significant increase in the
percentage of cells with detectable RR formation at both
0.2 mM and 0.05 mM of Ribavirin (p=0.0001 for 0.2 mM and
0.05 mM compared to untransfected and siCTPS1 transfected cells
by Fisher’s exact test). For the 2 mM Ribavirin treatment,
although RR were induced in 100% of cells transfected with
siIMPDH or siCTPS1, knockdown of IMPDH2 showed a
decrease in the size of RR (with the average length of rod at
4.6 mm in siIMPDH2 transfected versus 6.9 mm in untransfected)
along with the number of RR per cell (4.5 RR/cell in siIMPDH2
transfected versus 7.1 RR/cell in untransfected, p=0.0024 by t-
test) when compared to untransfected cells at 2 mM Ribavirin. At
0.2 mM Ribavirin, increased formation of RR was observed in
cells with reduced levels of IMPDH2 (42.9% of cells in siIMPDH2
transfected vs 21.6% for siCTPS1, p=0.0048). At 0.05 mM
Ribavirin, siIMPDH2 transfected cells had 22.4% cells with
shorter rods (Figure 9D) compared to siCTPS1 transfected cells
with 3.6% (Figure 9C, p=0.0001). Thus, the data show that the
formation of RR by Ribavirin was sensitive to the total IMPDH2
level and excess intracellular IMPDH2 made cells resistant to the
formation of RR. Therefore, RR formation appeared to depend
on the molecular ratio of Ribavirin to IMPDH2 and cells with a
lowered IMPDH2 level could be induced to form RR at low
concentration of Ribavirin.
RR expression in embryonic stem cells
From the data presented in the previous sections, except for the
unique case of the INOVA HEp-2 cells, various cultured cell types
did not consistently express RR unless induced with one of the
CTPS1/IMPDH2 inhibitors. The next question was whether
certain cell types were uniquely capable of expressing RR in the
absence of inducers. ESCs are highly proliferative cells that can
self-renew and are pluripotent. Undifferentiated, uninduced ESCs
were found to express RR (Figure 10B) similar to those described
in HEp-2 cells (Figure 1A) with 1 or 2 RR per cell. Interestingly,
unlike HEp-2 cells or mouse 3T3 cells (Figure 10A), where only
,10% of cells had rings, .90% of ESC expressed rings, and ,5%
of cells had rods (Figure 10B). In contrast, ESCs that were
differentiated with retinoic acid (RA) for 4 days no longer
expressed RR (Figure 10C), but those differentiated ESCs
remained capable of RR formation upon treatment of 2 mM
Acivicin for 24 h and the RR phenotype was similar to the original
undifferentiated ESC (Figure 10D). RR expression could be
induced in multiple cancerous and primary cells, but RR were
found to be expressed in untreated stem cells.
Discussion
In this study, a novel cytoplasmic structure was identified by
human autoantibodies produced by patients with chronic hepatitis
C virus (HCV) infection through ANA testing. Our preliminary
Figure 6. Inhibition of CTPS1-induced formation of RR in
several human cancer cell lines. Induction of RR observed in human
cancer cell lines HeLa (A), CAL 27 (B), THP-1 (C), and HCT116 (D) when
treated with 2 mM DON in culture for 24 h, fixed, and co-stained with
human anti-RR serum It2006 (green) and rabbit anti-giantin (red).
Untreated controls showed few or no RR. The percentage of cells with
RR displayed for each condition is shown in the upper right corner with
the total number of cells counted indicated in parentheses. Bar, 5 mm.
doi:10.1371/journal.pone.0029690.g006
Figure 7. Inhibition of CTPS1-induced formation of RR in
mouse primary cardiomyocytes, fibroblasts, and endothelial
cells. Mouse primary cardiomyocytes prepared together with fibro-
blasts and endothelial cells, were treated with 2 mM DON and cultured
for 24 h. Cells were co-stained with human anti-RR serum IT2006
(green) and mouse anti-actinin monoclonal antibody (red). Nuclei
counterstained with DAPI (blue). Actinin-positive cardiomyocytes (A, B,
red) as well as actinin-negative fibroblast or endothelial cells (A, C) all
show distinct rods. The percentage of cells with RR displayed is shown
in the lower right corner with the total number of cells counted
indicated in parentheses (A, all cells; B, actinin-positive cardiomyocytes
only; C; actinin-negative fibroblast and endothelial cells). Bar, 10 mm.
doi:10.1371/journal.pone.0029690.g007
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vector (D–F) for 24 h and followed by 2 mM Ribavirin incubation for 24 h. Cells were stained with rabbit anti-IMPDH2 (red) and counterstained with
DAPI (Blue). GFP-IMPDH2 transfected cells (T) did not express RR while untransfected cells showed rods (arrows) and rings (arrowheads). RR were
detected in both GFP vector transfected and untransfected cells. Bar, 10 mm.
doi:10.1371/journal.pone.0029690.g008
Figure 9. RR formation increasingly sensitive to Ribavirin when IMPDH protein level is reduced by specific siRNA knockdown. HeLa
cells were either untransfected, transfected with siCTPS1, or siIMPDH2 for 44 h and followed by incubation of Ribavirin at various concentrations for
an additional 4 h. (A) IMPDH2 expression was monitored by Western blot using rabbit anti-IMPDH2 antibody. Serial dilutions of untreated HeLa cell
lysates (100%, 50%, and 25%) were used to help to comparatively quantitate the degree of protein knockdown. The level of actin was used as a
loading control. Relative IMPDH2 protein levels were quantified using image J and normalized to the serial dilution standards. (B) Percentage of cells
with RR were quantified using Mayachitra Imago with a range of 131 to 298 cells counted per data point. Cells treated with siIMPDH2 had a
significant increase in percentage of cells with RR at 0.2 mM and 0.05 mM of Ribavirin analyzed by Fisher’s exact test. (C–D) Representative image of
cells at the lowest concentration of Ribavirin transfected with siCTPS1 or siIMPDH2. Arrows, rods; arrowhead, ring. Bar, 5 mm.
doi:10.1371/journal.pone.0029690.g009
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antibodies. Only ,25% of HCV patients treated with both
interferon-a and Ribavirin, the most common combination
therapy for HCV infection, had anti-RR antibodies while none
of the untreated HCV patients developed an anti-RR response.
Based on our present data that primary cells exposed to Ribavirin
could form RR in vitro, one can speculate that cells from patients
exposed to Ribavirin will form RR. Aggregated/modified IMPDH
(and CTPS) in RR in these Ribavirin treated patients may become
antigenic and trigger an autoimmune response.
Most subcellular organelles disassemble prior to mitosis and
reform after cell division. Although some mitotic cells were devoid
of RR and thus suggesting RR might disassemble prior to mitosis,
either the disassembly of RR was incomplete or the disassembly
did not occur at all in many cells, since ,50% of mitotic cells,
including all stages, clearly retained RR (data not shown). At least
one autoantigen, IMPDH2, recognized by the human anti-RR
prototype serum It2006 was determined through IP-Western
analysis. Co-localization studies determined CTPS1 to be a second
component of RR. Inhibitors of the two enzymes induced
formation of RR in cells that did not express RR during
continuous culture. RR induction could be accomplished with
low nanomolar inhibitor concentrations. Overexpression of
IMPDH2 inhibited formation of RR while knockdown of
IMPDH2 protein allowed for more sensitive induction of RR
with ultralow concentrations of Ribavirin that normally did not
induce RR. Furthermore, in HeLa cells overexpressing IMPDH2,
higher concentrations of Ribavirin were not effective and could
only induce remnant of RR. Therefore, the induction of RR is
inhibitor-concentration dependent with lower levels of IMPDH2
favoring RR formation in the presence of low level of Ribavirin.
Since CTPS1 and IMPDH2 are major enzymes controlling the
biosynthetic pathways for CTP and GTP, respectively, the
formation of RR using multiple independent inhibitors of these
enzymes implies that this cytoplasmic structure is linked to these
cellular metabolic pathways. It is, however, acknowledged that
DON and Acivicin are not completely specific for CTPS1 but are
not expected to affect activity of IMPDH [21]. The observations
that the formation of RR is sensitive to the concentration of
IMPDH2 (Figure 9) and that RR are present in some cases in
untreated cells suggest that the formation of RR is linked to the
functional level of these enzymes in cellular regulation related to
ribonucleotide (CTP or GTP) synthesis. Since the inhibition of
CTPS1 causes formation of RR that can be detected using an
IMPDH2 antibody, CTPS1 and IMPDH2 must aggregate
together to form RR, although demonstration of their direct
molecular interaction is lacking. Due to the large size of these
structures, one may speculate that there are many other
components involved in RR formation and some of these may
serve as molecular linkers to facilitate interaction between CTPS
and IMPDH. Future biochemical analyses are needed to explore
whether there is direct interaction of CTPS and IMPDH.
Figure 10. Uninduced mouse embryonic stem cells expressed predominantly cytoplasmic rings that were disassembled during
retinoic acid-induced differentiation and reassembled when treated with Acivicin. (A) Mouse 3T3 cells for comparison shown with both
rods (80–90%, arrowhead) and rings (10–20%, arrows). (B) Undifferentiated mouse ESCs shown with ,90% rings (arrows) and few rods. (C) ESCs
treated with RA for 4 days showed no RR. (D) RR were induced in these RA-differentiated cells by treatment with 2 mM Acivicin for 24 h. Cells were
stained with human anti-RR serum It2006 (green, A–D) and co-stained with rabbit anti-giantin (red, A, B only). Nuclei counterstained with DAPI (blue).
The percentage of ESCs with RR displayed for each condition is shown in the lower right corner with the total number of cells counted indicated in
parentheses. Bar, 5 mm.
doi:10.1371/journal.pone.0029690.g010
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Since our initial observation of RR over four years ago,
morphologically similar structures were identified in five recent
reports [17,22–25] in addition to two previous reports [7,26]. The
first report of RR-like structures may be the 1987 study by
Willingham et al. [26]. They reported a cytoplasmic ‘‘fibrillar
structure’’ identified by an IgG3 monoclonal antibody generated
from a Balb/c mouse immunized with mouse tumor cells. These
structures were identified using transmission electron microscopy
and immuno-electron microscopy as ‘‘large single paracrystalline
arrays of individual filaments’’ not enclosed by a lipid bilayer
membrane. Their structures were similar in appearance and
number per cell to the RR in this study. The target recognized by
the monoclonal antibody, an unknown 58 kDa protein in
immunoprecipitation of [
35S]-methionine radiolabeled cell lysate,
was referred to as nematin (from nematodes). The identity of the
antigen was not elucidated [26]. Similar to our results, they
reported that these structures were unrelated to tubulin or
vimentin and evolutionarily conserved in human, mouse, and
rat. It was also reported that the nematin structure occurred
following thawing of stored frozen cells [26] such as HEp-2, 3T3,
and NRK cells, also observed in our laboratory.
The second study reporting RR-like structures was by Ji et al.
identifying IMPDH2 protein aggregates formed from inhibition of
enzymatic activity through MPA treatment [7]. The structures
were identified by immunofluorescence and electron microscopy
analysis [26]. Further analyses revealed that the aggregates were
reversible with the addition of guanosine and its derivatives. The
structures in that study and in ours were induced with two
independent IMPDH2 inhibitors, MPA versus Ribavirin. Both
inducers inhibit IMPDH2, but MPA is a noncompetitive and
reversible inhibitor [27], while Ribavirin is a nonreversible
inhibitor.
Ingerson-Mahar et al. demonstrated that CTPS formed
filaments in C. crescentus [23]. Identification of the structure was
through electron cryotomography along the inner curvature of C.
crescentus. The metabolic enzyme CTPS has a bifunctional role, as
a filament that regulates curvature and performs its catalytic
function. A key difference was that treatment of DON in this study
dissociated the CTPS filaments in bacteria, while DON induced
the formation of RR in mammalian cells in our study. The latter
finding on the effect of DON on mammalian cells is completely
consistent with data in a recent report by Chen et al [25].
Other recent reports identified RR-like structures in both yeast
and Drosophila. Noree et al. identified four novel filaments that were
identified by screening a yeast GFP strain collection [24]. Through
inhibition of CTPS, they determined that filaments were
comprised of inhibited CTPS, similar to our results. In addition,
they were able to visualize CTPS filaments in the Drosophila egg
chamber, a subset of gut cells and neurons. Another report also
identified an intracellular structure containing CTPS in Drosophila
cells [17]. The structures, referred to as cytoophidia, were
identified in ovary cells and other tissues [25,28]. GFP protein
trap fly stocks from the Carnegie Protein Trap Library identified
CTPS as the component of cytoophidia. RR and cytoophidia may
be the same conserved structures among different species [25].
Ramer et al. identified a large intracellular neuronal organelle
that occurs in a subset of adult rat sympathetic ganglion neurons
[22]. The structure, identified by immunohistochemistry plus
confocal and electron microscopy, occurred mainly in a toroidal
shape, but also as twists or rods. The structures, referred to as
loukoumasomes or donut-like structures, were recognized by a
monoclonal antibody that was raised against neuron-specific bIII-
tubulin, but not recognized by other bIII-tubulin antibodies. One
difference between this and our study was the increased toroidal
(ring) structures in neurons, while we observed more rods than
rings in all induced cancer cells, but more rings than rods in ESCs.
Spontaneous RR versus inhibitor-induced RR
Although RR may appear to be highly conserved as discussed
above, our preliminary screening in mouse liver, kidney, and
spleen using indirect immunofluorescence did not detect these
structures. Undifferentiated ESCs express RR without the use of
inhibitors while differentiated cells do not express RR and,
interestingly, differentiated cells were still capable of RR formation
upon induction with a CTPS1 inhibitor. However, this should not
be interpreted as de-differentiation back to stem cells. A note of
caution is needed, as it is not clear whether ESCs RR are
structurally and functionally the same as those of cancer cells
treated with inhibitors. One clear phenotypic difference is in the
ratio of rods to rings in ESCs (rod:ring=1:9) compared to all other
cell types with induced RR and including the RR detected in
INOVA HEp-2 slides (rod:ring=9:1). It is unclear whether the
spontaneous formation of RR in ESCs is related to the functional
activity of IMPDH2 or CTPS1 but one can speculate that, since
ESCs are metabolically highly active, the spontaneous formation
of RR is likely to suggest that RR-associated IMPDH2 in ESCs are
functionally active. The ability to self-renew and pluripotency are
two unique properties of stem cells, and these properties may have
an effect on IMPDH2 (and CTPS1) activity. Once stem cells
differentiate, the cellular requirement of IMPDH2 (and/or
CTPS1) may change and the RR is no longer needed. One
biological function of RR, as demonstrated here, is related to
CTP/GTP synthetic pathways.
Similar to ESCs, the INOVA HEp-2 cells were actively dividing
cells (before fixation), based on the relatively high number of
detectable mitotic cells. Thus, RR in INOVA HEp-2 cells are also
likely to be functional in terms of their component CTPS1 and
IMPDH2. One can speculate that the requirement of CTP and
GTP in rapidly dividing cells favors the aggregation of these
nucleotides synthetic enzymes to possibly enhance their functional
activities. This is consistent with our experience that, while freshly
thawed cells can demonstrate up to 25% cells with RR in first or
second cell passages, cell confluence is often associated with the
complete loss of RR expression – IMPDH2/CTPS1 no longer
assemble in the cytoplasm. This argues for the formation of RR to
be associated with a high requirement of intracellular CTP/GTP
and the associated biosynthetic enzymes are assembled into RR,
which can enhance their synthetic activity.
In contrast, inducible RR in cancer cells, as well as primary
cells, are composed of inactivated enzymes based on the presence
of an inhibitor added to induce these structures. Higher expression
of IMPDH2 inhibited formation of RR by comparable levels of
inhibitors. Lower expression of IMPDH2, as in the partial
knockdown experiment, promoted formation of RR with a lower
concentration of inhibitor. The apparent difference between ESCs
with likely active RR-associated IMPDH2/CTPS1 versus the
inhibitor-induced RR with inactive enzymes may be explained as
follows. When HEp-2 cells are exposed to an inhibitor, such as
Ribavirin, the lower production of GTP may trigger the response
for the biosynthetic enzyme to assemble into oligomer/polymer
configuration to favor an increase in enzyme activity, consistent
with the speculation above that ESCs have a strong GTP/CTP
requirement to maintain active cell proliferation. Once RR is
formed, Ribavirin – an irreversible inhibitor, ‘‘locks’’ the
configuration of RR, making the enzymes inactive.
In summary, RR formation is regulated by the inhibition of
CTPS1 and IMPDH2, important in purine and pyrimidine
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importance of these enzymes in RNA and DNA synthesis suggests
that RR may play a role in cell division. In addition, both CTPS1
and IMPDH2 aggregate together to form the RR structure and
inhibition of one will cause the aggregation of the other
component with RR. Studies have demonstrated that CTPS1
and IMPDH2 are aberrantly expressed in different cancers [4,29].
However, as CTPS1 and IMPDH2 are differentially expressed,
the formation of RR in cells may help regulate their overall
activities. Further characterization and understanding of RR may
lead to a new biomarker for diseases or novel markers for stem
cells.
Materials and Methods
Cell culture
HeLa (human cervical cancer), HEp-2 (human epidermoid larynx
carcinoma), and HCT116 (human colon cancer) were cultured in
DMEM containing 10% Fetal Bovine Serum (FBS). Human oral
cancer cells CAL 27 were cultured in DMEM containing 10% FBS
and 1.5 g/L sodium bicarbonate. THP-1, human monocytes, and
K562, human erythroleukemia cells, were cultured in RPMI 1640
with 25 mM HEPES, and 10% FBS. All cells were cultured in a
37uC incubator with 5% CO2. Adherent cell lines were maintained
at50% confluence. Suspension cellswere maintained at an optimum
concentration of 10
6 cells/mL. All media contained 100 I.U./ml
penicillin and 100 mg/ml streptomycin.
Embryonic stem cell culture and differentiation
The murine R1 ESCs were obtained from Dr. Andre Nagy
(University of Toronto) and maintained according to Hamazaki
et al. [30]. ESCs were differentiated with 1 mM retinoic acid for 4
consecutive days as described [31].
Mouse cardiomyocyte collection and preparation
The mouse cardiomyocytes were harvested and prepared
according to Chan et al. [32].
Human autoantibodies
Autoantibodies with reactivity to RR were selected by authors
GC and CAvM during routine ANA screening assay. All three
human anti-RR sera used in this study were from patients with
chronic HCV infection and were de-identified samples. These sera
were selected largely due to their relative specificity in RR staining
and in available quantity to allow further analyses. Serum It2006
provided by GC, and serum 604 and 609 provided by CAvM, are
considered prototype sera for anti-RR. The clinical characteriza-
tion of these patients and others with anti-RR will be summarized
in a subsequent report [33].
Immunoprecipitation
Immunoprecipitation of [
35S]-methionine-labeled K562 cells
for the analysis of the proteins recognized by human autoimmune
sera was performed as described [34].
Indirect immunofluorescence
HEp-2 cell slides (INOVA Diagnostics, San Diego, CA) or
various adherent cell types cultured in 8-well chamber slides (BD
Falcon) were used for indirect immunofluorescence as described
[35,36]. The 8-well chamber slides were prepared using ,60,000
cells per well in 500 mL of media. Non-adherent cells were
prepared using the cytospin method to transfer cells onto glass
slides as described [37]. Fixation methods included acetone at
220uC for 5 min, acetone/methanol (3:1) at 220uC for 10 min,
and 3% paraformaldehyde in PBS at room temperature for
10 min followed by 0.1% triton-X/PBS for another 10 min. For
co-staining studies the following primary antibodies were used:
rabbit anti-giantin [38], anti-pericentrin (a gift from Dr. Marvin
Fritzler, University of Calgary), anti-Drosophila CTPS1 and pre-
immune serum (a gift from Dr. Jim Wilhelm, University of
California, San Diego), anti-IMPDH2 (Abcam, Cambridge, MA:
ab75790; Proteintech, Chicago, IL: 12948-1-AP), mouse anti-
actin, anti-actinin (Sigma-Aldrich, St. Louis, MO: A7811), anti-
tubulin, and anti-vimentin, and human anti-RR serum It2006,
604, and 609. To validate that the rabbit anti-Drosophila CTPS1
serum recognized human CTPS1, a full-length human CTPS1
cDNA (IMAGE id 3355881, OpenBiosystems, Thermo Scientific)
was used as a template in an in vitro transcription and translation
reaction (TNT, Promega) to generate [
35S]-methionine labeled
translation products. The latter was shown to be immunoprecip-
itated by the rabbit anti-Drosophila CTPS1 serum and not by the
pre-immune serum from the same rabbit.
Induction of RR formation using CTPS or IMPDH
inhibitors
Acivicin (Enzo Life Sciences, Ann Arbor, MI; BML-El113-
0010) and Ribavirin (Sigma-Aldrich; R9644) were solubilized in
water to 100 mM and 50 mM stock concentration, respectively. 6-
diazo-5-oxo-L-norleucine (DON, Sigma-Aldrich; D2141) was
solubilized in DMEM to a stock concentration of 100 mM. Cells
were seeded as monolayers and allowed to attach for 24 h.
Subsequently, CTPS1 or IMPDH2 inhibitors were added to
various final concentrations from 0.2 mM to 2 mM and were kept
in a cell incubator for times ranging from 15 min to 48 h.
siRNA knockdown
All siRNAs used in this study were obtained from Dharmacon
RNA Technologies (Lafayette, CO). The siRNAs were dissolved in
molecular biology grade water and the resulting 20 mM stock was
stored in aliquots at 280uC before use. The two predesigned
siRNAs were: ON-TARGET plus SMART pool siRNA Human
CTPS1 (target sequences: UAACAUUGAUGCAGGAACA, AG-
ACUAAACCUACCCAGAA, GGUGUUAUAUCAGGAAUU-
G, and GUAUGCAGGUGCUCAAAUC), siGENOME SMAR-
Tpool siRNA IMPDH2 (target sequences: GGACAGACCU-
GAAGAAGAA, GCACGGCGCUUUGGUGUUC, GGAAAG-
UUGCCCAUUGUAA, and CUAAAGAAAUAUCGCGGUA).
Transfection was performed using Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA) per the manufacturer’s instruction. The siRNA
was used at a final concentration of 100 nM. Knockdown
efficiency was determined by real-time PCR analysis using CTPS
primers (Applied Biosystems, Hs01041851_m1) or IMPDH2
primers (Applied Biosystems, Hs00168418_m1) plus Western blot
for protein expression.
Transfection of GFP plasmid
HeLa cells were seeded in 8 well chambers at 50–70%
confluency. Cells were transfected with 0.35 mg GFP-IMPDH2
(RG202977, OriGene, Rockville, MD) or a GFP vector alone
using 0.53 mg of Lipofectamine 2000. The transfected cells were
examined after 24 h directly as live cells or were processed for
indirect immunofluorescence.
Western blotting
Protein levels were analyzed as described [39] using rabbit anti-
CTPS (Abcam, 1:1000) or rabbit anti-IMPDH (Santa Cruz
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was crosslinked to protein A Sepharose beads as described [40]
and human It2006 was used for immunoprecipitation and mouse
monoclonal and rabbit anti-IMPDH from Santa Cruz Biotech-
nology were used for detection. Mouse anti-actin antibody 31G9
was used at 1:5,000 or ,1 mg/ml as a normalizer to control for
loading.
Statistical analysis
Cell counting was performed using Mayachitra Imago (Maya-
chitra, Santa Barbara, CA) to detect nuclei counterstained with
DAPI. Unpaired, two-tailed Student’s t-test and Fisher’s exact test
were used to compare independent groups. When appropriate,
Bonferroni’s adjustment for multiple comparisons was applied. For
all statistical analysis, Prism for Windows, version 5.0 (GraphPad
Software, San Diego, CA) was used.
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